Human Immunome Project
The Human Immunome Project (HIP) is a global nonprofit organization dedicated to decoding and modeling the immune system. It aims to generate the world’s largest and most comprehensive immunological dataset and build AI models of the immune system to transform health outcomes for everyone, everywhere. The organization is pioneering the next frontier in health and medicine by combining systems biology with artificial intelligence to unlock the secrets of immunity, improve longevity, and enhance quality of life worldwide.
Industries
Nr. of Employees
small (1-50)
Human Immunome Project
209 W. 29th Street, Suite 6178, New York, NY 10019
Products
Scientific strategy and public dataset/model releases
Published scientific strategy documents and the public release of consortium datasets and trained models to support downstream research.
Scientific strategy and public dataset/model releases
Published scientific strategy documents and the public release of consortium datasets and trained models to support downstream research.
Services
Coordinated, multi-site generation of standardized immunological data intended for use in public models and research.
Development and release of publicly accessible predictive and mechanistic AI models trained on consortium datasets.
Design of standardized study protocols and operational scaling strategies for multi-site immunological studies.
Facilitation and management of partnerships across academic, industry and governmental organizations to enable coordinated research and data sharing.
Activities to support local research capacity including training, infrastructure support, and technology transfer in under-resourced settings.
An outreach and awards program to solicit and fund high-quality proposals from early-stage researchers.
Coordinated, multi-site generation of standardized immunological data intended for use in public models and research.
Development and release of publicly accessible predictive and mechanistic AI models trained on consortium datasets.
Design of standardized study protocols and operational scaling strategies for multi-site immunological studies.
Facilitation and management of partnerships across academic, industry and governmental organizations to enable coordinated research and data sharing.
Activities to support local research capacity including training, infrastructure support, and technology transfer in under-resourced settings.
An outreach and awards program to solicit and fund high-quality proposals from early-stage researchers.
Expertise Areas
- Systems immunology
- Computational immunology and machine learning
- Large-scale cohort study design and execution
- Immunological assay development and repertoire sequencing
Key Technologies
- Next-generation sequencing
- Immune-receptor repertoire sequencing (BCR/TCR)
- Advanced immune monitoring assays
- Machine learning and AI for biological data
News & Updates
The organization congratulates Immunis, Inc. for receiving a prestigious XPRIZE Healthspan Semi-finalist award and announces a strategic leadership transition with Dr. Hans Keirstead becoming CEO.
The organization congratulates Immunis, Inc. for receiving a prestigious XPRIZE Healthspan Semi-finalist award and announces a strategic leadership transition with Dr. Hans Keirstead becoming CEO.